Deals, Development and Manufacturing

AstraZeneca Acquires Neogene Therapeutics for $320 Million

November 30, 2022

AstraZeneca inked a deal worth up to $320 million to purchase Neogene Therapeutics, a biotech start-up focused on T-cell receptor therapies.

Pfizer, Merck KGaA, and Immutep Enter into Second Clinical Trial Collaboration Agreement

November 30, 2022

The agreement will see Immutep and Merck KGaA, Darmstadt, Germany jointly fund the INSIGHT-005 study.

Merck Announces $1.35 Billion Acquisition of Imago BioSciences

November 28, 2022

Merck will purchase Imago BioSciences, a biotechnology company focused on bone marrow disorders, for approximately $1.35 billion.

Regeneron and Cytomx Announce $2 Billion Oncology Collaboration

November 22, 2022

The collaboration will see the companies develop investigational next-generation bispecific immunotherapies for cancer.

Biotech Startup Raises $5.4M to Develop AI-Designed Protein Machines and Cell Factories

November 21, 2022

Biotech startup, Cradle, has raised $5.4 million in seed funding with an AI-enabled design platform that allows for the synthetic building of cell factories to produce proteins.

CellVax and Theragent Form Manufacturing Pact for Novel Cancer Immunotherapy Drug Candidate

November 17, 2022

CellVax Therapeutics has selected Theragent, a new CDMO, to manufacture clinical trial material for a new Phase II prostate cancer immunotherapy drug candidate.

Sanofi and Insilico Medicine Ink $1.2 Billion Drug Development Deal

November 16, 2022

The deal will see Sanofi use Insilico’s AI drug discovery platform to advance up to six new drug development candidates.

Indivior Acquires Opiant for $145 Million

November 16, 2022

Indivior’s acquisition of Opiant grants them access to the company’s portfolio of investigational opioid overdose reversal agent, OPNT003.

Shimadzu and UMG Göttingen Enter Analytics Collaboration

November 08, 2022

The collaboration will see Shimadzu and UMG develop new clinical laboratory methods using LC-MS for TDM analysis.

Gerresheimer and Nelson Labs NV Announce E&L Partnership

November 02, 2022

Gerresheimer and Nelson Labs will work together to conduct extractables and leachables testing on upcoming primary packaging solutions.